Authors:
Burtness, B
Windsor, S
Holston, B
DiStasio, S
Staugaard-Hahn, C
Abrantes, J
Kneuper-Hall, R
Farber, L
Orell, J
Bober-Sorcinelli, K
Haffty, BG
Reiss, M
Citation: B. Burtness et al., Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting, CA J SCI AM, 5(4), 1999, pp. 224-229
Authors:
Burtness, BA
Psyrri, A
Rose, M
D'Andrea, E
Staugaard-Hahn, C
Henderson-Bakas, M
Clark, MB
Mechanic, S
Krause, D
Snyder, E
Cooper, RB
Abrantes, J
Corringham, R
Deisseroth, A
Cooper, DL
Citation: Ba. Burtness et al., A phase I study of paclitaxel for mobilization of peripheral blood progenitor cells, BONE MAR TR, 23(4), 1999, pp. 311-315